ArticleInterleukin-23 and its Receptor Expression (IL-23R) in Psoriatic and Psoriatic Arthritis Patients
ArticleInterleukin-23 and its Receptor Expression (IL-23R) in Psoriatic and Psoriatic Arthritis Patients
ArticlePeripheral Blood mRNA and Protein Levels of CCN1 and CCN3 in Psoriatic Arthritis: A Case-Control Study
ArticlePeripheral Blood mRNA and Protein Levels of CCN1 and CCN3 in Psoriatic Arthritis: A Case-Control Study
ArticleBlood Cell Indices in Ankylosing Spondylitis and Psoriatic Arthritis with Relation to the Disease Activity: A Cross-Sectional Study
ArticleBlood Cell Indices in Ankylosing Spondylitis and Psoriatic Arthritis with Relation to the Disease Activity: A Cross-Sectional Study
ArticleMolecular expression and single nucleotide polymorphisms of the IL17A gene among etanercept-treated rheumatoid arthritis patients
ArticleMolecular expression and single nucleotide polymorphisms of the IL17A gene among etanercept-treated rheumatoid arthritis patients
ArticleTOLL-LIKE RECEPTORS 4 AND 9 EXPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS AND DERMATOMYOSITIS: RELATION TO CLINICAL STATUS AND DISEASE ACTIVITY
ArticleTOLL-LIKE RECEPTORS 4 AND 9 EXPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS AND DERMATOMYOSITIS: RELATION TO CLINICAL STATUS AND DISEASE ACTIVITY
ArticleInterleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity
ArticleInterleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity